- Home
- KO vs AZN Comparison
KO vs AZN Comparison
Compare KO & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KO
- AZN
- Stock Information
- Founded
- KO 1886
- AZN 1992
- Country
- KO United States
- AZN United Kingdom
- Employees
- KO N/A
- AZN N/A
- Industry
- KO Beverages (Production/Distribution)
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- KO Consumer Staples
- AZN Health Care
- Exchange
- KO Nasdaq
- AZN Nasdaq
- Market Cap
- KO 286.8B
- AZN 252.9B
- IPO Year
- KO 1919
- AZN 1993
- Fundamental
- Price
- KO $68.62
- AZN $81.79
- Analyst Decision
- KO Strong Buy
- AZN Strong Buy
- Analyst Count
- KO 12
- AZN 2
- Target Price
- KO $78.00
- AZN N/A
- AVG Volume (30 Days)
- KO 15.7M
- AZN 5.3M
- Earning Date
- KO 10-21-2025
- AZN 11-06-2025
- Dividend Yield
- KO 2.98%
- AZN 1.87%
- EPS Growth
- KO 25.34
- AZN 28.86
- EPS
- KO 3.02
- AZN 5.31
- Revenue
- KO $47,663,000,000.00
- AZN $56,501,000,000.00
- Revenue This Year
- KO $5.92
- AZN $10.82
- Revenue Next Year
- KO $5.53
- AZN $5.99
- P/E Ratio
- KO $22.63
- AZN $15.49
- Revenue Growth
- KO 2.80
- AZN 15.00
- 52 Week Low
- KO $60.62
- AZN $61.24
- 52 Week High
- KO $74.38
- AZN $86.57
- Technical
- Relative Strength Index (RSI)
- KO 51.79
- AZN 46.75
- Support Level
- KO $68.16
- AZN $81.65
- Resistance Level
- KO $70.90
- AZN $84.22
- Average True Range (ATR)
- KO 0.90
- AZN 1.14
- MACD
- KO 0.07
- AZN -0.47
- Stochastic Oscillator
- KO 46.66
- AZN 3.97
About KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.